Patent File Information
Application Information
Applicants
Person No Name Address
7538916 OCULAR THERAPEUTIX, INC.
Inventors
Person No Name Address
7538907 Peter JARRETT 20 2 ND AVENUE APT 218 BURLINGTON, MA MASSACHUSETTS 01803 A.B.D.
7538908 Rami EL-HAYEK 42 CONCORD AVENUE NORWOOD, MA MASSACHUSETTS 02062 A.B.D.
7538909 Timothy JARRETT 200 WEST BROOKLINE STREET BOSTON, MA MASSACHUSETTS 02118 A.B.D.
7538910 Zachary LATTRELL 10 CUTTING DRIVE NEWBURYPORT, MA MASSACHUSETTS 01950 A.B.D.
7538915 Joseph IACONA 90 SCHOOL STREET APT3 SOMERVILLE, MA MASSACHUSETTS 02143 A.B.D.
7538912 Charles BLIZZARD 6 DANBURY ROAD NASHUA, NH NEW HAMPSHIRE 03064 A.B.D.
7538913 Michael GOLDSTEIN 3 HURLBUT STREET CAMBRIDGE, MA MASSACHUSETTS 02138 A.B.D.
7538914 Erica KAHN 271 MT. AUBURN STREET CAMBRIDGE, MA MASSACHUSETTS 02138 A.B.D.
7538911 Arthur DRISCOLL 14 GREY COACH LANE READING, MA MASSACHUSETTS 01867 A.B.D.
Invention Information
Name Of Invention Bir tirozin kinaz inhibitörü içeren oküler implant
Summary Of Invention Buluş, bir retina hastalığının uzun bir süre tedavisi için bir hidrojel içinde dağılmış bir tirozin kinaz inhibitörü içeren bir sürekli salımlı biyobozunur oküler implant ile ilgilidir.
Attorney Information
Name UĞUR GÜRŞAD YALÇINER
YALÇINER PATENT VE DAN. LTD. ŞTİ.
Address Tunus Caddesi No:85/3-4 06680 - ÇANKAYA/ ANKARA
Priority Information
Date of Priority Priority Number Country of Priority
25-03-2020 US 202062994391P US
24-04-2020 WO 2020US29827 WO
27-10-2020 US 202063106276P US
11-02-2021 US 202163148463P US
Classes of The Invention
IPC
A61K9/00
A61K47/10
A61K31/4439
A61F9/00
A61F 2/14
Patent Application Procedures
Date Date of Notification Operation Document
17-03-2025 Yıllık Ücret Ödeme Talebi
12-03-2024 Yıllık Ücret Ödeme Talebi
27-07-2023 Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
26-07-2023 EPO'dan Gelen Patent Fasikül
Publications
Publication Date Description
21-08-2023 Avrupa Patent Fasiküllerinin İlanı
Payment Dates
Row Year Payment Date Amount Paid (₺)
4 2024 12-03-2024 2111.73
5 2025 17-03-2025 4680.0